Elutia Inc. Files 8-K on Financials
Ticker: ELUT · Form: 8-K · Filed: Mar 7, 2024 · CIK: 1708527
| Field | Detail |
|---|---|
| Company | Elutia Inc. (ELUT) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
TL;DR
Elutia Inc. dropped an 8-K detailing financials - check it out.
AI Summary
Elutia Inc. filed an 8-K on March 7, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits. The company, formerly known as Aziyo Biologics, Inc. until June 5, 2017, is incorporated in Delaware and headquartered in Silver Spring, Maryland.
Why It Matters
This 8-K filing provides investors with crucial updates on Elutia Inc.'s financial performance and operational status, which can influence investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not inherently present new risks.
Key Players & Entities
- ELUTIA INC. (company) — Registrant
- March 7, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Silver Spring, MD (location) — Principal executive offices
- AZIYO BIOLOGICS, INC. (company) — Former company name
- June 5, 2017 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Elutia Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was this 8-K filed?
This 8-K was filed on March 7, 2024.
What was Elutia Inc. previously named?
Elutia Inc. was formerly named Aziyo Biologics, Inc.
In which state is Elutia Inc. incorporated?
Elutia Inc. is incorporated in Delaware.
Where are Elutia Inc.'s principal executive offices located?
Elutia Inc.'s principal executive offices are located at 12510 Prosperity Drive, Suite 370, Silver Spring, MD 20904.
Filing Stats: 532 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-03-07 16:24:44
Key Financial Figures
- $0.001 — hich registered Class A Common Stock, $0.001 par value per share ELUT The Nasdaq
Filing Documents
- tm248252d1_8k.htm (8-K) — 30KB
- tm248252d1_ex99-1.htm (EX-99.1) — 146KB
- tm248252d1_ex99-1img01.jpg (GRAPHIC) — 5KB
- 0001104659-24-031918.txt ( ) — 369KB
- elut-20240307.xsd (EX-101.SCH) — 3KB
- elut-20240307_lab.xml (EX-101.LAB) — 33KB
- elut-20240307_pre.xml (EX-101.PRE) — 22KB
- tm248252d1_8k_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On March 7, 2024, Elutia Inc. (the "Company" or "Elutia") issued a press release announcing its results for the fourth quarter and full year ended December 31, 2023. A copy of the Company's press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Exhibit Description 99.1 Press Release of Elutia Inc., dated March 7, 2024 104 Cover Page Interactive Data File (formatted as Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ELUTIA INC. (Registrant) Date: March 7, 2024 By: /s/ Matthew Ferguson Matthew Ferguson Chief Financial Officer